Canadian MMJ Producers Aurora and CanniMed Come to Terms in $1.1B Deal

In the most valuable cannabis industry deal to date, Canadian medical cannabis producers Aurora Cannabis Inc and CanniMed Therapeutics have entered into a support agreement that will create the most valuable cannabis company in the world. The deal, which comes months after Aurora set in motion a hostile takeover bid of CanniMed and led to the […]

Read More - -

Tags: , ,

Aurora Stock Climbs on Domestic and European MMJ Success; Firm Buys More CanniMed Stock

Canadian medical cannabis company Aurora Cannabis Inc. saw a 10 percent increase in their stock price on Tuesday after announcing they had sold 354 kilograms (780.4 pounds) of cannabis in Canada and Germany in November. The stock, traded on Canada’s Toronto Stock Exchange, opened Tuesday at CA$10.75 and closed at CA$11.82. Aurora announced its domestic […]

Read More - -

Tags: , , , ,

Canadian Regulators Make Initial Ruling in Aurora-CanniMed Takeover Saga

The Ontario (Canada) Securities Commission has issued a regulator ruling in Aurora Cannabis Inc.’s attempted hostile takeover of CanniMed Therapeutics Inc., indicating that any securities issued by CanniMed as a defense against the bid must be cease-traded, the Canadian Press reports. The ruling requires Aurora to amend its takeover bid circular and all related press […]

Read More - -

Tags: , ,

CanniMed Takes ‘Poison Pill’ in Attempt to Thwart Aurora Takeover

In the midst of the hostile takeover attempt by Aurora Cannabis, CanniMed Therapeutics has adopted a shareholder rights plan – or “poison pill” – preventing Aurora from buying more shares or entering in any new lock-up agreements with current shareholders. According to a press release, the purpose of the plan is to ensure CanniMed shareholders […]

Read More - -

Tags: , ,

Aurora Makes ‘Unsolicited Offer’ for CanniMed Takeover

Canada’s Aurora Cannabis Inc. is seeking to takeover CanniMed Therapeutics in an all-stock $455 million deal, according to a Bloomberg report. The deal values CanniMed stock at C$24 a share, 57 percent above Tuesday’s Toronto Stock Exchange closing price. Aurora Executive Vice President Cam Battley told Bloomberg that the firm is “making a very big […]

Read More - -

Tags: , ,

You are viewing cannabis news and information related to CanniMed Therapeutics. View all cannabis news >>